J Vicuna-Kojchen, S Frenkel, T Siegal, E … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Methods: Files of all 56 patients with PCNSL, with or without intraocular
lymphoma (IOL), treated at Hadassah University Hospital during the years
1997–2007 were reviewed. Data on 46 patients for whom we had ... Cited by 2 - Related articles - BL Direct - All 3 versions
S Goldberg, S Frenkel, EZ Blumenthal, A … - Ophthalmology, 2007 - Elsevier The vitreoretinal form of intraocular lymphoma is non-Hodgkin's B-cell lymphoma,
which commonly occurs in conjunction with CNS lymphoma. [1] and [2] Treatment
protocols currently suggest the use of systemic chemotherapy, 3 which fails ... Cited by 3 - Related articles - All 14 versions
A Galor, SJ Ference, AD Singh, MS Lee, GHJ … - American Journal of Ophthalmology, 2007 - Elsevier Seven (54%) of 13 patients were identified with new macular retinal pigment
epithelium (RPE) changes after BBBD treatment. The RPE changes consisted of fine
clumps of hyperpigmentation in the foveal region associated with variable ... Cited by 3 - Related articles - All 13 versions
JK Wang, CM Yang, CP Lin, YD Shan, AY Lo, … - Japanese journal of ophthalmology, 2006 - Springer PCNSL has a poor prognosis, with a 5-year survival rate of less than 5%. 3
Presentations of IOL can occur before or after neurological manifestations.The
most common symp- toms are floaters and blurred vision. 4 It can masquerade ... Cited by 3 - Related articles - All 3 versions
- ►nih.gov HN Sen, CC Chan, G Byrnes, RN Fariss, RB … - Ocular immunology and inflammation, 2008 - informahealthcare.com Purpose: To describe the clinical course of a patient with multiple recurrences
of primary intraocular lymphoma (PIOL). Design: Interventional case report,
Methods: Retrospective chart review. Results: A 57-year-old female treated ... Cited by 3 - Related articles - BL Direct - All 5 versions
K Isobe, Y Ejima, S Tokumaru, N Shikama, G … - Leukemia & lymphoma, 2006 - informahealthcare.com This study evaluated the clinical features and treatment outcome of 15 patients
with primary intraocular lymphoma. There were nine females, with a median age of
68 years. Thirteen patients presented with bilateral lesions and median ... Cited by 10 - Related articles - BL Direct - All 7 versions
SK Kim, CC Chan, DJ Wallace - Current oncology reports, 2005 - Springer Introduction Primary intraocular lymphoma (PIOL) is a disease entity in which
malignant lymphoid cells invade the vitreous body, retina, or optic nerve head.
PIOL is considered a sub- set of primary central nervous system lymphoma ... Cited by 11 - Related articles - All 3 versions
PW Hardwig, JS Pulido, JC Erie, KH Baratz, H … - American journal of ophthalmology, 2006 - Elsevier To investigate whether intravitreal methotrexate could be safely administered
and improve vision in patients with ocular disease other than primary central
nervous system lymphoma (PCNSL). ... Patients with various clinical ... Cited by 4 - Related articles - All 21 versions
A Berenbom, RM Davila, HS Lin, JW Harbour - Eye, 2006 - nature.com Intravitreal chemotherapy for primary intraocular lymphoma (PIOL) increasingly
is promoted as an alternative to radiotherapy, owing to putative high failure
and complication rates of the latter modality. Our aim was to confirm ... Cited by 11 - Related articles - BL Direct - All 3 versions
- ►iovs.org JF Mineo, A Scheffer, C Karkoutly, L Nouvel, … - Investigative Ophthalmology & Visual Science, 2008 - ARVO RESULTS. Inoculation of 38C13 CD20 + cells in the eye or the brain resulted in
tumor occurrence after a median of 15 days or 22 days, respectively, with
histologic characteristics closely resembling those of PIOL and PCNSL. ... Cited by 6 - Related articles - All 3 versions
